EGFR and glioblastoma: Although the GSC model, irrespective of its culture conditions, displays several advantages compared to classical GBM cell lines, it suffers from one important drawback related to the loss of specific key point mutations, a scenario that is critically epitomized by the constitutively active EGFRvIII receptor and/or EGFR amplification issues [104].